Arrowhead Pharmaceuticals · 2 hours ago
Laboratory Assistant I, Quality Control
Verona, WI
Full-time
Onsite
Entry Level
$43K/yr - $47K/yr
1+ years expArrowhead Pharmaceuticals is a clinical stage biopharmaceutical company focused on developing innovative drugs for genetic diseases. The Lab Assistant supports the Quality Control team by maintaining laboratory cleanliness, managing inventory, and preparing chemical reagents for laboratory use.
BiotechnologyHealth CareNanotechnologyPharmaceutical
No H1B
Responsibilities
Ability to closely follow written and verbal instructions
Ability to clearly and concisely document reagent preps using lab notebooks or controlled forms
Good verbal and written communication skills
Maintains glassware for the lab
Maintains cleanliness and orderliness of work areas
Maintains stocks of lab supplies and materials, ordering consumables, reagents, and chemicals as requested
Follows safety procedures for chemical handling
Prepares solutions and chemical reagents for laboratory use
Executes training requirements, applies relevant SOPs and associated procedural guides
Perform tasks in a timely manner
Works collaboratively with others
Quickly communicates issues to senior staff and/or management and assist in finding resolutions
Maintains clear, concise, and accurate documentation and records according to Good Documentation Practices
Embraces cGMP requirements for all associated work
Remains flexible with changing priorities
Qualification
Required
Minimum of a high school diploma
1 years' experience working in a lab setting
Preferred
Associate's Degree
Experience in a GLP or GMP environment
Benefits
Competitive salaries
Excellent benefit package
Company
Arrowhead Pharmaceuticals
Arrowhead Pharmaceuticals is a biotechnology company that focuses on the development of medicine to treat diseases with a genetic origin.
501-1000 employees
Funding
Current Stage
Public CompanyTotal Funding
$1.62BKey Investors
Sarepta TherapeuticsSixth StreetSilence Therapeutics
2024-11-26Post Ipo Equity· $325M
2024-08-08Post Ipo Debt· $400M
2024-01-03Post Ipo Equity· $450M
Leadership Team
Christopher Anzalone
President and Chief Executive Officer
Bruce Given
Chief Operating Officer
Recent News
2025-12-27
Los Angeles Business Journal
2025-12-24
Morningstar.com
2025-12-16
Company data provided by crunchbase